Wednesday, January 14

Healthcare

Eagle Pharmaceuticals receives delisting notification from Nasdaq

08/29/20241 Min Read

delisting Eagle Nasdaq notification Pharmaceuticals receives

Previous ArticleFDA approves Illumina's TruSight Oncology biomarker test

Next Article Arcus Biosciences secures $250M term loan facility